Surprisingly, the BioT analysis results showed that high levels of BioT could also reduce the risk of clear cell ovarian cancer, while high levels of DHEAS could reduce the risk of mucinous ovarian cancer. Here, SULT2A1 is linked to ovarian clear cell cancer.